Regarding the expression levels of the Il-6 and IL-1beta genes, in the stroke group, there was no difference in the expression of the Il-6 gene (0.00013-fold) as compared to the control group (0.00011-fold); meanwhile, there was a significant increase in the expression of this gene in the telmisartan group (0.00019-fold) relative to the control. The gene discussed is IL1B; the disease is stroke disorder.